Wealthspring Capital’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-369,763
Closed -$4.24M 94
2024
Q3
$4.24M Sell
369,763
-6,382
-2% -$72.6K 5.23% 6
2024
Q2
$4.24M Buy
376,145
+5,959
+2% +$66.9K 4.93% 6
2024
Q1
$4.11M Sell
370,186
-12,115
-3% -$134K 4.86% 6
2023
Q4
$4.19M Buy
382,301
+1,305
+0.3% +$14.2K 5.48% 5
2023
Q3
$4.11M Buy
380,996
+92,910
+32% +$997K 7.03% 4
2023
Q2
$3.07M Buy
288,086
+275,086
+2,116% +$2.91M 4.26% 8
2023
Q1
$136K Sell
13,000
-1,750
-12% -$18.2K 0.22% 90
2022
Q4
$152K Buy
+14,750
New +$150K 0.23% 142

Other funds holding RENE

Wealthspring Capital's RENE Position: Q4 2024 in Review

Wealthspring Capital sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 369,763 shares — an estimated $4.24M sold.

Wealthspring Capital first reported a position in RENE in Q4 2022 and held it in 8 quarters. The position peaked at $4.24M in Q3 2024. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Wealthspring Capital reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Wealthspring Capital sold 369,763 Cartesian Growth Corp II shares in Q4 2024, an estimated $4.24M.
  • Wealthspring Capital first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 8 quarters.
  • Wealthspring Capital's Cartesian Growth Corp II position peaked at $4.24M in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Wealthspring Capital's 13F filing for Q4 2024, filed 5 Feb 2025.